Oscillo Biosciences Revenue

Biotechnology Research • Farmington, Connecticut, United States • 1-10 Employees

Oscillo Biosciences revenue & valuation

Annual revenue	$684,440
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,200,000
Total funding	No funding

Key Contact at Oscillo Biosciences

Ji Chul Kim

Co-Founder And Chief Science Officer

Company overview

Headquarters	Farmington, Connecticut, United States
Phone number	+18602824215
Websites	oscillobiosciences.com oscilloscape.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Biotech, Neuroscience, Medical Device, Healthy Aging, Neurotechnology, Neural Networks, Signal Processing, Alzheimer'S Disease, Music Technology, Neuromodulation, Parkinson'S Disease, Neurostimulation, Optogenetics, Neuroplasticity, Digital Therapeutics, Brain Stimulation, Neurotech, Human Auditory Neuroscience, Music Perception And Cognition
Founded	2017
Employees	1-10
Socials

Oscillo Biosciences Email Formats

Oscillo Biosciences uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@oscillobiosciences.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@oscillobiosciences.com	100%

About Oscillo Biosciences

Oscillo Biosciences is a pre-commercial biotech company developing medical devices and digital therapeutic platforms to treat serious neurodegenerative diseases like Alzheimer's Disease, Parkinson's, aphasia, dyslexia and others. More than 6 million Americans suffer from dementia due to Alzheimer’s disease, and the incidence is rising at an alarming rate. Alzheimer’s disease is the 5th leading cause of death among Americans age 65 and older. Among the top 10 causes of death, it is the only one for which there is no known cure. Our approach is predicated on the understanding that brain rhythms supporting memory and cognition are disrupted in people with Alzheimer’s disease. Recent studies have proven that stimulating brain waves at specific frequencies can bring about changes at the molecular level, diminishing brain plaques, untangling neural networks, and improving memory and cognition. We are currently developing a prescription medical device and digital therapeutic that work together to restore healthy brain function in patients with Mild Cognitive Impairment and Alzheimer’s disease.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Founder/Owner

Employees by Department

Oscillo Biosciences has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Oscillo Biosciences has never raised funding before.

Oscillo Biosciences Tech Stack

Discover the technologies and tools that power Oscillo Biosciences's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Gravity Forms

Form builders

Swiper

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Yoast SEO

SEO

Google Workspace

Google Tag Manager

Tag managers

GoDaddy

Hosting

Frequently asked questions

Oscillo Biosciences is located in Farmington, Connecticut, US.

You can reach Oscillo Biosciences at +18602824215.

Oscillo Biosciences generates an estimated annual revenue of $684,440. This revenue figure reflects the company's market position and business performance in its industry.

Oscillo Biosciences has an estimated valuation of $2,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Oscillo Biosciences was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Oscillo Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Oscillo Biosciences

Ji Chul Kim

Co-Founder And Chief Science Officer

4.8

40,000 users